Regeneron Pharmaceuticals Inc.

In News

Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

MarketWatch - Sep 15, 2026

How Investors Are Reacting To Regeneron Pharmaceuticals Stock (REGN) Trial Disclosure Lawsuits - simplywall.st

simplywall.st - Sep 17, 2026

Regeneron stock gains analyst support after strong quarterly figures - AD HOC NEWS

AD HOC NEWS - Sep 20, 2026

Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance

Yahoo Finance - Sep 15, 2026

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of September 14, 2026 in Regeneron Pharmaceuticals, Inc. Lawsuit - REGN - PR Newswire

PR Newswire - Sep 14, 2026

REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire

GlobeNewswire - Sep 14, 2026

US FDA approves Regeneron's rare bone disorder drug - Reuters

Reuters - Aug 20, 2026

Why Regeneron Pharmaceuticals (NASDAQ:REGN) Is Back in Focus? - Kalkine Media

Kalkine Media - Sep 18, 2026

Here’s Why The Fund Sold Regeneron Pharmaceuticals (REGN) - Yahoo Finance

Yahoo Finance - Sep 09, 2026

Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch

MarketWatch - Sep 10, 2026

REGN 2-DAY DEADLINE ALERT: Regeneron Pharmaceuticals, Inc. - GlobeNewswire

GlobeNewswire - Sep 12, 2026

Levi & Korsinsky Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGN - PR Newswire

PR Newswire - Sep 14, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment